{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.59","value":"6.4"},{"groupId":"OG001","spread":"2.00","value":"6.5"},{"groupId":"OG002","spread":"2.17","value":"6.6"},{"groupId":"OG003","spread":"1.61","value":"6.1"}]}],"title":"Overall QOL"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.80","value":"6.9"},{"groupId":"OG001","spread":"1.97","value":"7.0"},{"groupId":"OG002","spread":"1.91","value":"7.2"},{"groupId":"OG003","spread":"1.39","value":"6.5"}]}],"title":"Mental QOL"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.54","value":"5.7"},{"groupId":"OG001","spread":"2.11","value":"5.8"},{"groupId":"OG002","spread":"2.22","value":"5.9"},{"groupId":"OG003","spread":"1.65","value":"5.8"}]}],"title":"Physical QOL"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.68","value":"6.5"},{"groupId":"OG001","spread":"1.99","value":"6.8"},{"groupId":"OG002","spread":"2.03","value":"6.7"},{"groupId":"OG003","spread":"1.80","value":"6.3"}]}],"title":"Emotional QOL"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.08","value":"5.5"},{"groupId":"OG001","spread":"2.12","value":"5.5"},{"groupId":"OG002","spread":"2.34","value":"5.4"},{"groupId":"OG003","spread":"2.01","value":"5.1"}]}],"title":"Social Activity Level"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.54","value":"7.4"},{"groupId":"OG001","spread":"1.81","value":"7.4"},{"groupId":"OG002","spread":"2.07","value":"7.3"},{"groupId":"OG003","spread":"1.99","value":"6.8"}]}],"title":"Spiritual QOL"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.46","value":"4.5"},{"groupId":"OG001","spread":"2.96","value":"4.3"},{"groupId":"OG002","spread":"3.02","value":"3.9"},{"groupId":"OG003","spread":"2.42","value":"4.2"}]}],"title":"Pain Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.16","value":"4.1"},{"groupId":"OG001","spread":"2.72","value":"3.8"},{"groupId":"OG002","spread":"2.88","value":"3.7"},{"groupId":"OG003","spread":"2.24","value":"4.0"}]}],"title":"Pain Severity"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.59","value":"5.6"},{"groupId":"OG001","spread":"2.02","value":"5.5"},{"groupId":"OG002","spread":"2.14","value":"5.6"},{"groupId":"OG003","spread":"1.60","value":"5.4"}]}],"title":"Fatigue"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.81","value":"4.1"},{"groupId":"OG001","spread":"2.20","value":"3.9"},{"groupId":"OG002","spread":"2.36","value":"4.6"},{"groupId":"OG003","spread":"1.67","value":"4.2"}]}],"title":"Anxiety"}],"denoms":[{"counts":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"60"},{"groupId":"OG002","value":"58"},{"groupId":"OG003","value":"57"}],"units":"Participants"}],"description":"To compare the effects of the 3 different epoetin alfa dosing schedules and a darbepoetin alfa schedule. Linear Analogue Self Assessment (LASA) consists of 10 single-item numeric analogue scales on a scale of 0 to 10. Higher scores indicate better quality of life (QOL) on overall QOL, mental, physical, emotional spiritual QOL and Social activity; and constant pain, highest pain severity, level of fatigue and anxiety. Average scores across all time points for each item were calculated.","dispersionType":"Standard Deviation","groups":[{"description":"Patients receive Epoetin alfa 40,000 units subcutaneously every week for 15 weeks (15 doses)","id":"OG000","title":"Epoetin Alfa - 40k Weekly"},{"description":"Patients receive Epoetin alfa 80,000 units subcutaneously every 3 weeks for 15 weeks (5 doses)","id":"OG001","title":"Epoetin Alfa - 80k Every 3 Weeks"},{"description":"Patients receive Epoetin alfa 120,000 units subcutaneously every 3 weeks for 15 weeks (5 doses)","id":"OG002","title":"Epoetin Alfa - 120k Every 3 Weeks"},{"description":"Patients receive Darbepoetin alfa 500 micrograms (mcg) subcutaneously every 3 weeks for 15 weeks (5 doses)","id":"OG003","title":"Darbepoetin Alfa - 500 mcg Every 3 Weeks"}],"paramType":"MEAN","populationDescription":"All patients that were evaluable per protocol with QOL data.","reportingStatus":"POSTED","timeFrame":"Weeks 4, 7, 10, 13 and 16","title":"Quality of Life as Measured by Linear Analogue Self Assessment Over All Follow-up Evaluation","type":"SECONDARY","unitOfMeasure":"units on a scale"}